In tamoxifen-resistant breast cancer cells, exosomes released by these cells might negatively regulate ADIPOQ expression in recipient cells, rendering more cancer cells tolerant to chemotherapy drugs upon interaction with surrounding drug-sensitive tumor cells [142]. Here, ADIPOQ is linked to breast cancer.